A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes

Daniel Todt, Toni Luise Meister, Barbora Tamele, John Howes, Dajana Paulmann, Britta Becker, Florian H. Brill, Mark Wind, Jack Schijven, Natalie Heinen, Volker Kinast, Baxolele Mhlekude, Christine Goffinet, Adalbert Krawczyk, Jörg Steinmann, Stephanie Pfaender, Yannick Brüggemann, Eike Steinmann*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has created a significant threat to global health. While respiratory aerosols or droplets are considered as the main route of human-to-human transmission, secretions expelled by infected individuals can also contaminate surfaces and objects, potentially creating the risk of fomite-based transmission. Consequently, frequently touched objects such as paper currency and coins have been suspected as potential transmission vehicle. To assess the risk of SARS-CoV-2 transmission by banknotes and coins, we examined the stability of SARS-CoV-2 and bovine coronavirus, as surrogate with lower biosafety restrictions, on these different means of payment and developed a touch transfer method to examine transfer efficiency from contaminated surfaces to fingertips. Although we observed prolonged virus stability, our results indicate that transmission of SARS-CoV-2 via contaminated coins and banknotes is unlikely and requires high viral loads and a timely order of specific events.

Original languageEnglish
Article number102908
Pages (from-to)1-16
JournaliScience
Volume24
Issue number8
DOIs
Publication statusPublished - 20 Aug 2021

Bibliographical note

Funding Information:
We thank Victor M Corman and Terry C Jones from Charité Universitätsmedizin Berlin, Germany for sequencing of the SARS-CoV-2 strain used in this study. We thank Thorsten Wolff, Jessica Schulz, and Christian Mache from the Robert-Koch Institute (Fachbereich 17) for providing the B.1.1.7 isolate (alpha variant) and René Scholtysik of University Hospital Essen for establishing the PCR for virus variant determination. Moreover, we would like to thank all members of the Department of Molecular & Medical Virology at the Ruhr University Bochum for support and fruitful discussion. E.S. was supported by the VIRus ALliance NRW (VIRAL) from Ministry of Culture and Science of the State of North Rhine-Westphalia (323-8.03-151826) This study was in parts financed by the European Central Bank .

Funding Information:
We thank Victor M Corman and Terry C Jones from Charit? Universit?tsmedizin Berlin, Germany for sequencing of the SARS-CoV-2 strain used in this study. We thank Thorsten Wolff, Jessica Schulz, and Christian Mache from the Robert-Koch Institute (Fachbereich 17) for providing the B.1.1.7 isolate (alpha variant) and Ren? Scholtysik of University Hospital Essen for establishing the PCR for virus variant determination. Moreover, we would like to thank all members of the Department of Molecular & Medical Virology at the Ruhr University Bochum for support and fruitful discussion. E.S. was supported by the VIRus ALliance NRW (VIRAL) from Ministry of Culture and Science of the State of North Rhine-Westphalia (323-8.03-151826) This study was in parts financed by the European Central Bank. Conceptualization, D.T. B.T. J.H. F.H.B. J.S.T. S.P. E.S; data curation, D.T. T.L.M. D.P. B.B. M.W. J.S; formal analysis, D.T. and J.S; funding acquisition, B.T. J.H. and E.S; investigation, T.L.M. D.P. B.B. N.H. V.K. and B.M.; methodology, D.T. F.H.B. S.P. and E.S; project administration, B.T, J.H. F.H.B. and E.S; resources, F.H.B. B.M. C.G. A.K. J.S.T. S.P. and E.S. validation, D.T. T.L.M. D.P. B.B. F.H.B. M.W. J.S. and E.S; visualization, D.T. and Y.B; writing ? original draft, D.T. Y.B. S.P. and E.S; writing ? review & editing, all authors. D.T. receives consulting fees from the European Central Bank. E.S. receives consulting fees from the European Central Bank and is a member of the scientific advisory board of Dr. Brill + Partner GmbH. F.H.B. is executive partner of Dr. Brill + Partner GmbH.

Publisher Copyright:
© 2021 The Author(s)

Funding

We thank Victor M Corman and Terry C Jones from Charité Universitätsmedizin Berlin, Germany for sequencing of the SARS-CoV-2 strain used in this study. We thank Thorsten Wolff, Jessica Schulz, and Christian Mache from the Robert-Koch Institute (Fachbereich 17) for providing the B.1.1.7 isolate (alpha variant) and René Scholtysik of University Hospital Essen for establishing the PCR for virus variant determination. Moreover, we would like to thank all members of the Department of Molecular & Medical Virology at the Ruhr University Bochum for support and fruitful discussion. E.S. was supported by the VIRus ALliance NRW (VIRAL) from Ministry of Culture and Science of the State of North Rhine-Westphalia (323-8.03-151826) This study was in parts financed by the European Central Bank . We thank Victor M Corman and Terry C Jones from Charit? Universit?tsmedizin Berlin, Germany for sequencing of the SARS-CoV-2 strain used in this study. We thank Thorsten Wolff, Jessica Schulz, and Christian Mache from the Robert-Koch Institute (Fachbereich 17) for providing the B.1.1.7 isolate (alpha variant) and Ren? Scholtysik of University Hospital Essen for establishing the PCR for virus variant determination. Moreover, we would like to thank all members of the Department of Molecular & Medical Virology at the Ruhr University Bochum for support and fruitful discussion. E.S. was supported by the VIRus ALliance NRW (VIRAL) from Ministry of Culture and Science of the State of North Rhine-Westphalia (323-8.03-151826) This study was in parts financed by the European Central Bank. Conceptualization, D.T. B.T. J.H. F.H.B. J.S.T. S.P. E.S; data curation, D.T. T.L.M. D.P. B.B. M.W. J.S; formal analysis, D.T. and J.S; funding acquisition, B.T. J.H. and E.S; investigation, T.L.M. D.P. B.B. N.H. V.K. and B.M.; methodology, D.T. F.H.B. S.P. and E.S; project administration, B.T, J.H. F.H.B. and E.S; resources, F.H.B. B.M. C.G. A.K. J.S.T. S.P. and E.S. validation, D.T. T.L.M. D.P. B.B. F.H.B. M.W. J.S. and E.S; visualization, D.T. and Y.B; writing ? original draft, D.T. Y.B. S.P. and E.S; writing ? review & editing, all authors. D.T. receives consulting fees from the European Central Bank. E.S. receives consulting fees from the European Central Bank and is a member of the scientific advisory board of Dr. Brill + Partner GmbH. F.H.B. is executive partner of Dr. Brill + Partner GmbH.

Keywords

  • Methodology in biological sciences
  • Microbiology
  • Virology

Fingerprint

Dive into the research topics of 'A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes'. Together they form a unique fingerprint.

Cite this